RAPT Therapeutics Expands Leadership Team with Multiple Key Hires
May 04, 2022 08:00 ET
|
RAPT Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...
Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX Deployment
June 07, 2021 07:00 ET
|
Renalytix AI plc.
NEW YORK and SALT LAKE CITY, June 07, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) today announced a series of key hires to drive its commercialization strategy in the United...
Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
December 22, 2020 08:00 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical Officer
November 17, 2020 16:05 ET
|
Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
OncoCyte Strengthens Board of Directors with Addition of Industry Veteran Melinda Griffith
July 24, 2019 08:00 ET
|
OncoCyte Corporation
ALAMEDA, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, molecular diagnostic tests for the early detection and management of cancer, today...
AxoGen Appoints Eric Sandberg as Chief Commercial Officer
January 22, 2019 07:00 ET
|
AxoGen, Inc.
ALACHUA, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
CardioDx Presents Comparative Effectiveness Claims Analysis Highlighting the Clinical Value of the Corus® CAD Precision Medicine Blood Test in Elderly Patients at the Gerontological Society of America 2018 Annual Meeting
December 19, 2018 08:00 ET
|
CardioDx, Inc.
REDWOOD CITY, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, presented results of a comparative effectiveness...
Results of a Comparative Effectiveness Claims Analysis from a Large Commercial Payer, Presented at the AHA Scientific Sessions 2018, Reinforce the Clinical Utility of the Corus® CAD Blood Test in the Outpatient Assessment of Obstructive CAD
December 17, 2018 11:00 ET
|
CardioDx, Inc.
– Patients Who Received the Corus CAD Test Experienced Significantly Lower Rates of Downstream Invasive Coronary Angiography, CAD-Related ER and Doctor Visits, Hospitalizations, and Noninvasive...
Metacrine Appoints Hubert Chen, M.D. as Chief Medical Officer and Andrew Guggenhime to the Board of Directors
September 06, 2018 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., a biotechnology company developing therapies to benefit patients with liver and gastrointestinal diseases (GI), today announced the...
American Heart Association's New Scientific Statement Deems the Corus CAD Test Valid and Useful for Clinicians Evaluating Obstructive CAD
September 28, 2017 08:30 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Sep 28, 2017) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today that in a Scientific Statement by the...